The 19th Annual BIO CEO & Investor Conference

See you in 2017!

February 13-14, 2017
The Waldorf Astoria New York

Sign up to receive the latest updates about this conference as well as other BIO events.

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

Our therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma.  Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.

"Much of my time was spent in the educational sessions, which I would rank as some of the best I have seen at any conference — ever."

-Rob Wright, Chief Editor, Life Science Leader 


 Download 2015 Event Summary



 Download Conference Prospectus



Photos from 2016 BIO CEO & Investor Conference